Accelovance — Melbourne, Florida

Accelovance is a clinical research site located in Melbourne, Florida, United States 32935.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Accelovance has participated in 18 clinical trials.

Therapeutic areas: Influenza, Meningitis, Meningococcal, Meningococcal Disease.

Sponsors: Alachua Government Services, Inc., Pfizer, Novartis Vaccines.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Melbourne

Browse all research sites in Florida · View every site in Melbourne

• Melbourne Internal Medicine Associates / Century Research Associates, Holmes Regional Medical Center Hospital
• University Clinical Research-DeLand, LLC dba Accel Research Sites
• Florida Eye Associates
• Optimal Research
• GSK Investigational Site
• Health First Holmes Regional Medical Center
• Pfizer Investigational Site
• Research Site
• Holmes Regional Medical Center
• Novo Nordisk Investigational Site
• Melbourne Internal Medicine Associates

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accelovance?

Accelovance has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accelovance conducted?

Accelovance has 18 clinical trials on record. Their work covers Influenza, Meningitis, Meningococcal, Meningococcal Disease.

Is Accelovance accredited by Crixeo Clinical Trials?

Accelovance has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accelovance?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.